Literature DB >> 8965142

Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole.

K Fukuchi1, H Kusuoka, Y Watanabe, T Fujiwara, T Nishimura.   

Abstract

UNLABELLED: To evaluate the utility of 99mTc-labeled nitroimidazole (BMS) in the detection of ischemic or reperfused myocardium, we performed dual-tracer autoradiography with BMS and [125I]iodoantipyrine (IAP).
METHODS: In open-chest rats, the left coronary artery was ligated to produce 15- or 60-min ischemia followed by reperfusion or 60-min ischemia without reperfusion. BMS was injected just before ligation, 1 min before reperfusion or 15 min after reperfusion.
RESULTS: In the area at risk, regional myocardial blood flow (rMBF) evaluated by IAP recovered to the level in the nonischemic septum in all hearts, except in 60-min occlusion without reperfusion. In myocardium reperfused after 15-min ischemia (stunned), normalized BMS uptake (%BMS) in the area at risk was significantly increased only when BMS was injected before ischemia. When BMS was injected before 60-min ischemia or just before reperfusion, %BMS was significantly higher at the marginal zone of infarction than in the infarcted area. In contrast, %BMS was significantly lower in the infarcted area when BMS was injected during reperfusion. After 60 min of occlusion without reperfusion (permanent occlusion), rMBF in the area at risk was significantly decreased as was %BMS. In the peripheral zone of the area at risk, rMBF was significantly reduced, but %BMS was significantly increased.
CONCLUSION: BMS images stunned myocardium only when it is injected before ischemia, while it images the area at risk subjected to prolonged ischemia when it is injected up to the time of reperfusion. The infarcted area can be negatively visualized when BMS is injected after reperfusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8965142

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

Review 1.  Imaging of angiogenesis.

Authors:  Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

2.  99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.

Authors:  J Hoffend; G Linke; A Mohammed; C P Tiefenbacher; M Eisenhut; U Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-07       Impact factor: 9.236

Review 3.  Molecular imaging of hypoxia with radiolabelled agents.

Authors:  Gilles Mees; Rudi Dierckx; Christel Vangestel; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-30       Impact factor: 9.236

Review 4.  Use of radionuclide imaging in acute coronary syndromes.

Authors:  Brian G Abbott; Frans J Wackers
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

5.  Detection of viable myocardium with p-iodophenyl-9-(R,S)-methylpentadecanoic acid in ischemic rat myocardium.

Authors:  Shinji Hasegawa; Hideo Kusuoka; Kaoru Maruyama; Hiroyuki Kurosawa; Syusaku Tazawa; Satoshi Ishida; Minoru Inoue; Masatsugu Hori; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

6.  Technetium 99m-HL-91: a potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion.

Authors:  G Johnson; K N Nguyen; Z Liu; R D Okada
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.